mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
VANCOUVER, BC, Sept. 18, 2023 - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical")Β (CSE: PREV) (OTCQB: PRVCF)Β (FSE: 18H), is proud to announce that Endosane Pharmaceuticals GmbH will proceed with its research initiative focused on preclinical studies to evaluate the brain delivery characteristics of sol-gel technology and wheth... Read More...
VANCOUVER, BC, Sept. 12, 2023 - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical")Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an important chapter in the journey of PreveCeutical Medical Inc., a pioneering figure in the realm of medical technology. The Company unveils a comprehensive narrat... Read More...
VANCOUVER, BC, Aug. 31, 2023 - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical")Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it has entered into a Service Agreement dated effective September 1, 2023 (the "Agreement") with New to the Street Group LLC ("NTTS"), whereby NTTS will provide production and broadcasting serv... Read More...
VANCOUVER, BC, July 24, 2023 - PreveCeuticalΒ Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical is furthering the progress Cyclic peptides and uses thereof of its patent families.Β
PreveCeutical's patent family based on PCT/AU2021/051545 (P113135.PCT, Cyclic pep... Read More...
Vancouver, British Columbia--(Newsfile Corp. - August 17, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has received AU$1,227,902 cash rebate from the Australian Federal Government's Research and Development ("R&D") Incentive Program. The cas... Read More...
VANCOUVER,Β BC, Aug. 4, 2020 -Β PreveCeuticalΒ Medical Inc. (the "Company" or "PreveCeutical")Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce thatΒ it is preparing for clinical trials for its Sol-Gel COVID-19 program. (News Release dated May 4, 2020).
PreveCeutical believes that the cannabinoid Sol-gel may reduce the possibilit... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the appointment of Edward James Henderson as the Public Officer and Director of its subsidiary company, PreveCeutical (Australia) Pty Ltd. (the "Subsid... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that the current stage of the research of its disulfide linker technology in engineering analgesic peptides derived from endogenous pharmacology program... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce that it has successfully demonstrated that delivery efficiency can be tailored based on vector composition in its Dual Gene Therapy Research Program.This update of Preve... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 13, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical") is pleased to inform that the cannabis product required for its cannabinoid Sol-Gel program to address the COVID-19 pandemic (the "COVID-19 Sol-gel") (News Release dated May 4, 2020), was recei... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce successful results from its Cannabinoid sol-gel product development program.We have successfully conducted a three-month physico-chemical stability test on cannabinoid so... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce that it has successfully designed, screened and shortlisted a panel of smart-siRNA constructs with potent gene silencing activity (in vitro) in its Dual Gene Therapy Res... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 22, 2020) - PreveCeutical Medical Inc.Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β ("PreveCeutical"), is pleased to announce that on June 18th, 2020, it has contracted UniQuest Pty Ltd. ("UniQuest") to apply the cannabinoid sol-gel ("CBD Sol-Gel") technology to develop a nasal spray formulatio... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2020) - Β PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce that it has successfully developed 'Standard Operating Procedures' ("SOPs") allowing for the chemical fingerprinting (profiling) of cannabinoids present in its extracts... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical") provides the following information about certain promotional activities at the request of OTC Markets.On June 15, 2020, the Company was notified by OTC Markets that recently, certain materials ... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2020) - Β PreveCeutical Medical Inc.Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β ("PreveCeutical")Β is pleased to announce the successful completion of its cannabinoid sol-gel program (the "Sol-gel Program") with the University of Queensland ("UQ") and UniQuest Pty Ltd. ("UniQuest).The final... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2020) - PreveCeutical Medical Inc.Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β (the "Company" or "PreveCeutical"), is informing its shareholders that 134,151,350 common share purchase warrants (the "Warrants") issued in connection with the Company's June 29, 2018, non-brokered private plac... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the successful completion of its Cannabinoid Sol-Gel Delivery Program (the "Sol-gel Program").The Sol-gel Program developed and evaluated translatable fo... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to inform that, in connection with its previously announced extension to its successful cannabis sol-gel program (the "Program Extension") to address the COVID-19 pandemic (News Rele... Read More...
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2020) - Β PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical")Β announces that it has issued 95,600,253 common shares without par value in its capital (each, a "Share") to various arm's length creditors of the Company at a deemed issuance ... Read More...
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2020) - Β PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is pleased to announce that it is working on an extension to its successful cannabis sol-gel program to address the COVID-19 pandemic (the "Program Extension"). The Company is not making any ex... Read More...
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2020) - PreveCeutical Medical Inc.Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β (the "Company" or "PreveCeutical"), is pleased to announce an update to its Non-Addictive Analgesic (dynorphin pain peptide) Program.Following the identification and shortlisting of a panel of peptides showing ... Read More...
Vancouver, British Columbia--(Newsfile Corp. - January 14, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide a further update on its dual gene therapy research program (the "Dual Gene Therapy Program"), an important and fundamental aspect of which involves t... Read More...
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2020) - Β PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that after successfully developing water-based cannabis extract-infused soluble gel formulations (the "CBD Sol-gel Formulations") (see news release dated July 9, ... Read More...
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the successful completion of the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and de... Read More...
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2019) - PreveCeutical Medical Inc.Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β (the "Company" or "PreveCeutical"), is pleased to announce that it has received a cash refund of $616,802 AUD from the Australian Taxation Office under the Research and Development ("R&D") Tax Incentive Pr... Read More...
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide an update on its dual gene therapy program, an important and fundamental aspect of which involves the design, synthesis and screening of small inter... Read More...
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has recently reached a significant milestone in its research program for the development of non-addictive analgesics (the "Research Program"... Read More...
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into an option to purchase agreement (the "Option Agreement"), whereby PreveCeutical has granted to Asterion the right ... Read More...
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has completed the second phase of its soluble gel ("Sol-gel") drug delivery research and development program (the "Sol-gel Program"), by successfully develop... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the appointments of Keith Anderson and Mark Lotz to the board of directors of the Company (the "Board"), effective immediately.Stephen Van Deventer, Pre... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2019) - PreveCeutical Medical Inc.Β (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β (the "Company" or "PreveCeutical"), is pleased to provide positive results from research conducted for its dual gene therapy research program (the "Program").PreveCeutical previously identified four or more nove... Read More...
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)Β (the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount of $300,000 (the "Loan") pursuant to a loan agreement with the Company's Chairman and Chief Executive Officer, Mr. ... Read More...
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company's research team at the University of Queensland has been granted the necessary approvals from a local hospital's Human Ethics Committee to acquire an... Read More...
